Literature DB >> 21071914

Systemic inflammatory response and survival in patients with localised prostate cancer: 10-year follow-up.

Peter A McArdle, Tahir Qayyum, Donald C McMillan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21071914     DOI: 10.1159/000320242

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


× No keyword cloud information.
  5 in total

1.  Mean Platelet Volume Enhances the Diagnostic Specificity of PSA for Prostate Cancer.

Authors:  Wei Song; Ning Ding; Xiulin Zhang; Jiaxin Liu; Yuzhen Wang; Jieke Yan; Shuangde Liu
Journal:  Front Surg       Date:  2022-04-12

Review 2.  Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review.

Authors:  Alessandro Sciarra; Alessandro Gentilucci; Stefano Salciccia; Federico Pierella; Flavio Del Bianco; Vincenzo Gentile; Ida Silvestri; Susanna Cattarino
Journal:  J Inflamm (Lond)       Date:  2016-11-25       Impact factor: 4.981

Review 3.  Prognostic role of C-reactive protein in prostate cancer: a systematic review and meta-analysis.

Authors:  Zhu-Qing Liu; Li Chu; Jue-Min Fang; Xi Zhang; Hua-Xin Zhao; Yi-Jing Chen; Qing Xu
Journal:  Asian J Androl       Date:  2014 May-Jun       Impact factor: 3.285

4.  Clinical association of metabolic syndrome, C-reactive protein and testosterone levels with clinically significant prostate cancer.

Authors:  Enrique Gómez-Gómez; Julia Carrasco-Valiente; Juan Pablo Campos-Hernández; Ana Maria Blanca-Pedregosa; Juan Manuel Jiménez-Vacas; Jesus Ruiz-García; Jose Valero-Rosa; Raul Miguel Luque; María José Requena-Tapia
Journal:  J Cell Mol Med       Date:  2018-11-18       Impact factor: 5.310

5.  Efficiency of C-reactive protein in prognosis evaluation of prostate cancer: a systematic review and meta-analysis.

Authors:  Jianhui Du; Jianhua Lan; Jingjing Xiong; Hai Yang; Xiaohan Xu; Chaolai Tang; Guohua Huang; Qiao Ying; Jian Mu; Qiyi Hu
Journal:  Transl Cancer Res       Date:  2021-10       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.